EIF2A and infection: Although Axitinib-treated cells exhibited similar levels of ZIKV-induced eIF2α phosphorylation to DMSO-treated cells, Dabrafenib-treated cells exhibited reduced levels of eIF2α phosphorylation throughout the course of infection (Fig. 5B).